Cullinan Therapeutics Ratios (2020-2023) | CGEM

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Profitability
EBT Margin 7.49%
EBIT Margin 7.24%
EBITDA Margin 7.18%
Operating Margin 7.24%
Net Margin 7.49%
FCF Margin -8.00%
Efficiency
Assets Average 347.19M472.01M458.88M445.29M437.32M552.36M642.24M589.18M538.05M518.49M508.35M
Equity Average 335.01M464.12M452.01M435.42M422.42M512.04M595.37M560.58M510.34M492.61M484.20M
Invested Capital 200.31M469.70M458.54M445.47M425.37M419.47M604.62M586.13M535.03M485.65M499.57M468.82M
Leverage & Solvency
Equity Ratio 0.930.980.990.980.970.960.910.950.950.940.960.95
Valuation
Enterprise Value -208.90M1,375.24M786.83M306.47M383.99M-85.82M-294.24M-324.55M15.61M-256.95M-418.24M-481.23M435.93M
Market Capitalization 1,813.32M1,120.54M982.72M674.05M467.05M574.11M584.75M482.90M402.32M423.52M386.75M435.93M
Return Ratios
Return on Capital Employed -0.16%-0.24%0.31%0.23%0.26%0.22%-0.33%-0.37%
Return on Invested Capital 0.19%
Return on Assets -0.15%-0.19%0.20%0.16%0.19%0.12%-0.27%-0.31%
Return on Equity -0.15%-0.19%0.21%0.17%0.19%0.13%-0.29%-0.32%